Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.75
-0.29 (-4.80%)
At close: Nov 21, 2024, 4:00 PM
5.82
+0.07 (1.21%)
After-hours: Nov 21, 2024, 7:59 PM EST
Recursion Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,649 | 2,136 | 1,461 | 2,895 | - | - |
| Market Cap Growth | 12.27% | 46.15% | -49.51% | - | - | - |
| Enterprise Value | 1,312 | 1,800 | 1,059 | 2,317 | - | - |
| Last Close Price | 5.75 | 9.86 | 7.71 | 17.13 | - | - |
| PS Ratio | 21.67 | 47.92 | 36.68 | 284.42 | - | - |
| PB Ratio | 3.14 | 4.61 | 3.01 | 5.33 | - | - |
| P/TBV Ratio | 4.22 | 5.70 | 3.02 | 5.35 | - | - |
| EV/Sales Ratio | 20.13 | 40.38 | 26.58 | 227.62 | - | - |
| Debt / Equity Ratio | 0.17 | 0.11 | 0.10 | 0.00 | 0.05 | 0.16 |
| Asset Turnover | 0.10 | 0.07 | 0.06 | 0.02 | 0.02 | - |
| Quick Ratio | 3.95 | 4.24 | 5.51 | 11.27 | 11.35 | 10.48 |
| Current Ratio | 4.35 | 4.70 | 5.68 | 11.46 | 11.53 | 11.43 |
| Return on Equity (ROE) | -78.49% | -69.12% | -46.56% | -47.51% | -54.57% | - |
| Return on Assets (ROA) | -36.40% | -32.29% | -23.42% | -25.14% | -26.44% | - |
| Return on Capital (ROIC) | -44.73% | -41.64% | -28.43% | -28.62% | -30.76% | - |
| Earnings Yield | -22.90% | -15.36% | -16.39% | -6.44% | - | - |
| FCF Yield | -20.15% | -14.03% | -8.25% | -6.85% | - | - |
| Buyback Yield / Dilution | -23.57% | -18.41% | -40.04% | -475.48% | -0.98% | - |
| Total Shareholder Return | -23.57% | -18.41% | -40.04% | -475.48% | -0.98% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.